Quest Diagnostics
DGX
#862
Rank
โ‚น2.647 T
Marketcap
โ‚น23,986
Share price
0.35%
Change (1 day)
46.84%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

Earnings for Quest Diagnostics (DGX)

Earnings in 2026 (TTM): โ‚น139.85 Billion

According to Quest Diagnostics 's latest financial reports the company's current earnings are โ‚น11.84 Billion. In 2025 the company made an earning of โ‚น123.67 Billion, an increase over its 2024 earnings that were of โ‚น110.25 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Quest Diagnostics from 1997 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น139.85 B13.09%
2025 โ‚น123.67 B12.17%
2024 โ‚น110.25 B3.98%
2023 โ‚น106.03 B-8.5%
2022 โ‚น115.88 B-52.48%
2021 โ‚น243.87 B37.95%
2020 โ‚น176.78 B75.09%
2019 โ‚น100.96 B16.2%
2018 โ‚น86.88 B-10.1%
2017 โ‚น96.64 B-5.16%
2016 โ‚น101.90 B-1.54%
2015 โ‚น103.49 B31%
2014 โ‚น79.00 B-37.52%
2013 โ‚น126.45 B26.93%
2012 โ‚น99.63 B24.01%
2011 โ‚น80.34 B-27.7%
2010 โ‚น111.12 B-3.55%
2009 โ‚น115.21 B19.59%
2008 โ‚น96.34 B12.54%
2007 โ‚น85.61 B-11.7%
2006 โ‚น96.95 B13.49%
2005 โ‚น85.43 B9.02%
2004 โ‚น78.36 B13.19%
2003 โ‚น69.22 B36.03%
2002 โ‚น50.89 B63.07%
2001 โ‚น31.20 B65.49%
2000 โ‚น18.85 B1297.84%
1999 โ‚น1.34 B-73.37%
1998 โ‚น5.06 B-384.21%
1997 -โ‚น1.79 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
LabCorp
LH
โ‚น137.07 B-2.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
โ‚น3.91 B-97.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Psychemedics
PMD
-โ‚น0.18 Billion-100.13%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-โ‚น3.1 Billion-102.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
โ‚น47.03 B-66.40%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
-โ‚น0.74 Billion-100.53%๐Ÿ‡บ๐Ÿ‡ธ USA